{"id":"W2067725825","doi":"10.1016/j.bbmt.2014.12.028","title":"New Cancers after Autotransplantations for Multiple Myeloma","year":2014,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Terumo BCT; Genentech; Health Resources and Services Administration; Medac; Swedish Orphan Biovitrum; Otsuka America; Incyte; Allos Therapeutics; Ariad Pharmaceuticals; Actinium Pharmaceuticals; Blue Cross and Blue Shield Association; Kiadis Pharma; Therakos; Sigma-Tau Pharmaceuticals; Chimerix; Medical College of Wisconsin; Tarix Pharmaceuticals; StemCyte; Takeda Oncology; University of Minnesota; Amgen; Otsuka America Pharmaceutical; Teva Pharmaceutical Industries; HistoGenetics; WellPoint; U.S. Navy; Osiris Therapeutics; Celgene; Health Research; Onyx Pharmaceuticals; U.S. Department of Defense; Sanofi; Be The Match Foundation; GlaxoSmithKline","keywords":"Medicine; Incidence (geometry); Multiple myeloma; Cohort; Internal medicine; Confidence interval; Cumulative incidence; Population; Cancer; Relative risk; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007696395,0.0001018431,0.0001965034,0.00008952484,0.00004899286,0.000003925934,0.00002906662,0.00008959205,0.00003321592],"category_scores_gemma":[0.00002262993,0.00008410827,0.00006082294,0.00004850828,0.0000672047,0.00004195747,0.000002065094,0.00004592326,0.000001994143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000759513,"about_ca_system_score_gemma":0.00008473075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003415092,"about_ca_topic_score_gemma":0.0004271352,"domain_scores_codex":[0.999365,0.00003105702,0.0001708858,0.0001910634,0.00006214163,0.0001798665],"domain_scores_gemma":[0.9995156,0.0001831638,0.00004046493,0.0000827546,0.00004711829,0.0001309189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.005890833,0.0001463291,0.4438674,0.001245978,0.0005853582,0.00001897083,0.0009508266,0.000006849111,0.4744948,0.001376981,0.00008508494,0.07133064],"study_design_scores_gemma":[0.02959777,0.00308441,0.7214007,0.0003055716,0.001915376,0.0002032601,0.00005132761,0.001054642,0.2389628,0.001106859,0.002012317,0.0003049652],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9710954,0.000437601,0.02686376,0.0003115057,0.00007087263,0.0005517401,0.0003177827,0.00003065911,0.0003206937],"genre_scores_gemma":[0.9851216,0.0006270244,0.01331337,0.00006947951,0.00006805113,0.00009034382,0.0005490306,0.000009960795,0.0001511298],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2775333,"threshold_uncertainty_score":0.3429836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01415954141884324,"score_gpt":0.279854081265248,"score_spread":0.2656945398464048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}